Regenerar is pleased to invite you to tune into a compelling podcast that delves into the world of gene editing and gene reprogramming—two revolutionary technologies at the forefront of CRISPR and precision medicine. Dr.  Stefan Stricker, Group Leader at Helmholtz Zentrum Munich and Professor at the Biomedical Center (BMC), LMU Munich, shares cutting-edge insights and research shaping the future of biomedicine.

This podcast unpacks the following important topics:
– CRISPR’s shift beyond traditional gene editing
– Epigenetic reprogramming and its clinical potential
– Breakthroughs in regenerative therapies and chronic disease

CRISPR has already revolutionized the field of medicine by allowing precise edits to the genome. But what if, instead of making permanent changes to DNA, we could temporarily reprogram cells to alter their behavior? This approach could open up entirely new possibilities—enabling safer, more flexible treatments in areas like regenerative medicine, targeted cancer therapies, and interventions for neurodegenerative disorders. By using techniques such as RNA-based programming or transient epigenetic modifications, scientists may be able to control gene expression without the risks associated with permanent edits. This shift from editing the genome to dynamically programming cells could mark the next frontier in precision medicine.

This podcast was produced by Daily Dose of Honest Science and is available on their official YouTube channel https://www.youtube.com/watch?v=C0qqsYBVOF4